Retinoid-induced differentiation of neuroblastoma: Comparison between LG69, an RXR-selective analogue and 9-cis retinoic acid

European Journal of Cancer

Volumn 34, Issue 1, 1998, Pages 111-117

  Irving, H ^a,c   Lovat, P E ^a   Hewson, Q Campbell ^a   Malcolm, A J ^a   Pearson, A D J ^a   Redfern, C P F ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

9 cis retinoic acid; Apoptosis; Differentiation; Gene expression; Neuroblastoma; Proliferation; Retinoid

Indexed keywords

ALITRETINOIN; LG 69; RETINOID; RETINOID X RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION; HUMAN; HUMAN CELL; NEUROBLASTOMA; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BLOTTING, NORTHERN; CELL DIFFERENTIATION; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HUMANS; NEUROBLASTOMA; TETRAHYDRONAPHTHALENES; TRETINOIN;

EID: 0031938712     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)10027-2     Document Type: Article

References (48)

1. Iwata M, Koshinaga T, Okabe I, Kurosu Y, Esumi M. Biological characteristics of neuroblastoma with spontaneous tumor reduction-a case-report. J Fed Surg 1995, 30, 722-723.
2. Evans AE, Gerson J, Schnaufer L. Spontaneous regression of neuroblastoma. Natl Cancer Inst Monogr 1976, 44, 49-54.
3. Gushing H, Wolbach SB. Transformation of malignant paravertebral sympathoblastoma into benign ganglioneuroma. Am J Pathol\927, 3,203-216.
4. Griffin ME, Bolande RP. Familial neuroblastoma with regression and maturation to ganglioneurofibroma. Pediatrics 1969, 43, 377.
5. Aterman K, Schueller EF. Maturation of neuroblastoma to ganglioneuroma. Am J Dis Chad 1970, 120, 217-222.
6. Sidell N. Retinoic acid-induced growth-inhibition and morphologic differentiation of human neuroblastoma cells in vitro. J Natl Cancer Inst 1982, 68, 589-596.
7. Smith MA, Adamson PC, Balis FM, et al. Phase I and pharmacokinetic evaluation of all-fnzfts-retmoic acid in pediatrie patients with cancer. J Clin Oncol 1992, 10, 1666-1673.
8. Finklestein ]Z, Krailo MD, Lenarsky C, et al. 13-cis-retinoic acid (Nsc-122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy-report from the Children's-Cancer-Study-Group. Med Fed Oncol 1992, 20, 307-311.
9. Villabianca JG, Khan AA, Avramis VI, et al. Phase-I trial of 13-cis-retinoic acid in children with neuroblastoma following bonemarrow transplantation. J Clin Oncol 1995, 13, 894-901.
10. Lovat PE, Pearson ADJ, Malcolm A, Redfem CPF. Retinoic acid receptor expression during the in vitro differentiation of human neuroblastoma. Neurosci Letts 1993, 162, 109-113.
11. Haber M, Maadafiglio J, Bordow SB, et al. Expression of retinoic acid-responsive genes in primary neuroblastomas. In Evans AE, Biedler JL, Brodeur GM, D'Angio GJ, Nakagawara A, eds. Advances in Neuroblastoma Research 4 385. New York, Wiley-Liss, 1994, 245-252.
12. Clagettdame M, Verhalen TJ, Biedler JL, Repa JJ. Identification and characterization of all-wans-retinoic acid receptor transcripts and receptor protein in human neuroblastoma cells. Arch Biochem Biophys 1993, 300, 684-693.
13. Houle B, Rochetteegly C, Bradley WEC. Tumor-suppressive effect of the retinoic acid receptor-beta in human epidermoid lung-cancer cells. Proc Natl Acad Sei USA 1993, 90, 985-989.
14. Xu XC, Ro JY, Lee JS, Shin DM, Hong WK, Lotan R. Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res 1994, 54, 3580-3587.
15. Allegretto EA, McClurg MR, Lazarchik SE, et al. Transactivation properties of retinoic acid and retinoid-X receptors in mammalian-cells and yeast-correlation with hormone-binding and effects of metabolism. J Biol Ghent 1993, 26, 26625-26633.
16. Redfern CPF, Lovat PE, Malcolm AJ, Pearson ADJ. Differential-effects of 9-cis and all-mms-retinoic acid on the induction of retinoic acid receptor-beta and cellular retinoic acid-binding protein-Ii in human neuroblastoma cells. Biochem J 1994, 304, 147-154.
17. Han GY, Chang BS, Connor MJ, Sidell N. Enhanced potency of 9-cis versus all-rrarn retinoic acid to induce [he differentiation of human neuroblastoma cells. Differentiation 1995, 59, 61-69.
18. Plum LA, Clagettdame M. 9-cis-retinoic ;icid selectively activates the cellular retinoic acid-binding protdn-Ii gene in human neuroblastoma cells. Arch Biochem Biophys ] 995, 319, 457-463.
19. Kizaki M, Ikeda Y, Tanosaki R, et al. Effects of novel retinoic acid compound, 9-as-retinoic acid, on proliferation, differentiation, and expression of retinoic acid recepto r-alpha and retinoidX receptor-alpha RNA by HI-60 cells. Bhod 1993, 82, 35923599.
20. Sakashita A, Kizaki M, Pakkala S, et al. 9-cis-retinoic acid-effects on normal and leukemic hematopoiesis in vitro. Blood 1993, 81, 1009-1016.
21. Kizaki M, Nakajima H, Mori S, et al. Novel retinoic acid, 9-cis retinoic acid, in combination with all-wan s-retinoic acid is an effective inducer of differentiation of retinoic acid-resistant HI-60 cells. Blood 1994, 83, 3289-3297.
22. Anzano MA, Byers SW, Smith JM, et al. Prevention of breast-cancer in the rat with 9-a's-retinoic acid as a single-agent and in combination with tamoxifen. Cancer Res 1934, 54, 4614-4617.
23. Anzano MA, Peer CW, Smith JM, et al. Chemoprevention of mammary carcinogenesis in the rat-combined use of raloxifene and 9-a'i-retinoic acid. J Nail Cancer Inst 1996, 88, 123-125.
24. Gottardis MM, Lamph WW, Shalinsky D'R, Wellstein A, Heyman RA. The efficacy of 9-cis retinoic ucid in experimental models of cancer. Breast Cancer Research and Treatment 1996, 38, 85-96.
25. Lovat PE, Lowis SP, Pearson ADJ, Malcolm AJ, Redfern CPF. Concentration-dependent effects of 9-cis retinoic acid on neuroblastoma differentiation and proliferation m-vitro. Neurosci Letts 1994, 182, 29-32.
26. Redfern CPF, Lovat PE, Malcolm AJ, Pearson ADJ. Geneexpression and neuroblastoma cell differentiation in response to retinoic acid-differential effects of 9-cis and all-trans retinoic acid. Eurjf Cancer 1995, 31A, 486-494.
27. Lovat PE, Irving H, Malcolm AJ, Pearson ADJ, Redfern CPF. 9-cis retinoic acid-a better retinoid for the modulation of differentiation, proliferation and gene expression in human neuroblastoma. J Neuro-Oncol 1997, 31, 85-91.
28. Kurie JM, Lee JS, Griffin T, ei al. Phase-[ trial of 9-cis retinoic acid in adults with solid tumors. Clin Cancer Res 1996, 2, 287293.
29. Miller VA, Rigas JR, Benedetti FM, et al. Initial clinical-trial of the retinoid receptor pan agonist 9-cis retinoic acid. Clin Cancer Res 1996,2,471-475.
30. Adamson PC, Murphy RF, Godwin KA, Ulm EH, Balis FM. Pharmacokinetics of 9-ct's-retinoic acid in the rhesus-monkey. Cancer Res 1995, 55, 482-485.
31. Boehm MF, Zhang L, Badea BA, et al. Synthesis and structure-activity-relationships of novel retinoid-X receptor-selective retinoids. JMed Chem 1994, 37, 2930-2941.
32. Dawson MI, Jong L, Hobbs PD, et al. Conformational effects on retmoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid-X-receptor activity and selectivity. J Med Chem 1995, 38, 3368-3383.
33. Gillies RJ, Didier N, Demon M. Determination of cell number in monolayer cultures. Analytical Biochemistry 1986, 159, 109-113.
34. Wilkinson M. RNA isolation-a mini-prep method. Nucl Acids Res 1988, 16, 10933.
35. Redfern CPF, Todd C. Retinoic acid receptor expression in human skin keratinocytes and dermal fibroblasts in vitro. J Cell Sei 1992, 102, 113-121.
36. Siddiqui NA, Thomas EJ, Dunlop W, Redfern CPF. Retinoic acid receptors and retinoid-binding proteins in endometrial adenocarcinoma-differential expression of cellular retinoid-binding proteins in endometrioid tumors. Int J Cancer 1995, 64, 253263.
37. Lovat PE, Irving H, Annicchiarico-Petruzzelli M, et al. Apoptosis of neuroblastoma cells after differentiation with 9-cis retinoic acid and subsequent washout. J Nail Cancer Inst 1997, 89, 446452.
38. Sidell N, Altman A, Haussler MR, Seeger RC. Effects of retinoic acid (Ra) on the growth and phenotypic-expression of several human neuro-blastoma cell-lines. Exp Cell Res 1983, 148, 21-30.
39. Wyllie AH, Duvall E. Cell injury and death. In McGee JOD, Isaacson PG, Wright NA, eds. Oxford Textbook of Pathology 1. Oxford, Oxford University Press, 1992, 141-156.
40. Biedler JL, Helsan L, Spengler BA. Morphology and growth, tumorigenicity and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 1973, 33, 2643-2652.
41. Lovat, PE, Irving H, Annicchiarico-Petruzzelli M, et al. Retinoids in neuroblastoma therapy: distinct biological properties of 9-cis and a\\-trans retinoic acid. Ear J Cancer 1997, 33, 20752080.
42. Stunnenberg HG. Mechanisms of transactivation by retinoic acid receptors. BioEssays 1993, 15, 309-315.
43. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, Mangelsdorf DJ. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 1995, 9, 1033-1045.
44. Perlmann T, Jansson L. A novel pathway for vitamin-A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev 1995, 9, 769-782.
45. Villablanca JG, Khan AA, Avramis VI, Reynolds CP. Hypercalcemia-a dose-limiting toxicity associated with 13-cis-retinoic acid. Am J Fed Hematol Oncol 1993, 15, 410-115.
46. Gaetano C, Matsumoto K, Thiele CJ. Retinoic acid negatively regulates P34cdc2 expression during human neuroblastoma-differentiation. Cell Growth & Differentiation 1991, 2, 487-193.
47. Salbert G, Fanjul A, Piedrafita FJ, et al. Retinoic acid receptors and retinoid-X receptor-alpha down-regulate the transforming growth factor-beta(l) promoter by antagonizing Ap-1 activity. Mol Endocrinol 1993, 7, 1347-1356.
48. Fanjul A, Dawson MI, Hobbs PD, et al. A new class of retinoids with selective-inhibition of AP-1 inhibits proliferation. Nature 1994, 372, 107-111.